Neurodevelopmental and medical outcomes of persistent pulmonary hypertension in term newborns treated with nitric oxide
- PMID: 11953727
- DOI: 10.1067/mpd.2002.122730
Neurodevelopmental and medical outcomes of persistent pulmonary hypertension in term newborns treated with nitric oxide
Abstract
Objective: To determine the medical and neurodevelopmental outcome of children with moderately severe persistent pulmonary hypertension of the newborn (PPHN) treated with or without inhaled nitric oxide (I-NO).
Study design: Term infants with PPHN and a baseline oxygenation index of 24 +/- 9 at study entry were randomly assigned to early treatment with placebo or initial doses of I-NO (5, 20, and 80 ppm). Outcome was measured at approximately 1 year by frequency of hospitalization, growth, and neurodevelopmental and audiologic evaluation.
Results: Of 155 children enrolled, 144 survived, and there was follow-up for 133. No significant differences between the placebo and the I-NO groups were seen in any long-term outcome. Rehospitalization occurred in 22%, and growth did not differ. The composite neurodevelopment and audiologic outcome showed impairment in 46% of the infants. There were major neurologic abnormalities in 13%, cognitive delays in 30%, and hearing loss in 19% of the infants.
Conclusions: Moderately severe PPHN at 24 hours after birth is associated with high rates of rehospitalization and disability at 1 year. Adverse outcomes were the same in I-NO and control groups.
Comment in
-
Outcome in term infants treated with inhaled nitric oxide.J Pediatr. 2002 Mar;140(3):284-7. doi: 10.1067/mpd.2002.123700. J Pediatr. 2002. PMID: 11953722 No abstract available.
Similar articles
-
Outcome in term infants treated with inhaled nitric oxide.J Pediatr. 2002 Mar;140(3):284-7. doi: 10.1067/mpd.2002.123700. J Pediatr. 2002. PMID: 11953722 No abstract available.
-
Randomized, controlled trial of low-dose inhaled nitric oxide in the treatment of term and near-term infants with respiratory failure and pulmonary hypertension.Pediatrics. 1999 Nov;104(5 Pt 1):1089-94. doi: 10.1542/peds.104.5.1089. Pediatrics. 1999. PMID: 10545552 Clinical Trial.
-
Inhaled nitric oxide for the early treatment of persistent pulmonary hypertension of the term newborn: a randomized, double-masked, placebo-controlled, dose-response, multicenter study. The I-NO/PPHN Study Group.Pediatrics. 1998 Mar;101(3 Pt 1):325-34. doi: 10.1542/peds.101.3.325. Pediatrics. 1998. PMID: 9480993 Clinical Trial.
-
Beyond the inhaled nitric oxide in persistent pulmonary hypertension of the newborn.Pediatr Neonatol. 2018 Feb;59(1):15-23. doi: 10.1016/j.pedneo.2016.09.011. Epub 2017 Aug 10. Pediatr Neonatol. 2018. PMID: 28923474 Review.
-
Inhaled nitric oxide therapy for persistent pulmonary hypertension of the newborn.Acta Paediatr Jpn. 1995 Aug;37(4):425-30. doi: 10.1111/j.1442-200x.1995.tb03350.x. Acta Paediatr Jpn. 1995. PMID: 7572140 Review.
Cited by
-
Neurodevelopmental outcome in children between one and five years after persistent pulmonary hypertension of term and near-term newborns.Front Pediatr. 2024 Oct 23;12:1450916. doi: 10.3389/fped.2024.1450916. eCollection 2024. Front Pediatr. 2024. PMID: 39507497 Free PMC article.
-
Update on PPHN: mechanisms and treatment.Semin Perinatol. 2014 Mar;38(2):78-91. doi: 10.1053/j.semperi.2013.11.004. Semin Perinatol. 2014. PMID: 24580763 Free PMC article.
-
Persistent Pulmonary Hypertension of the Newborn.Neoreviews. 2015 Dec;16(12):e680-e692. doi: 10.1542/neo.16-12-e680. Neoreviews. 2015. PMID: 26783388 Free PMC article.
-
Comorbidities and Late Outcomes in Neonatal Pulmonary Hypertension.Clin Perinatol. 2024 Mar;51(1):271-289. doi: 10.1016/j.clp.2023.10.002. Epub 2023 Nov 7. Clin Perinatol. 2024. PMID: 38325946 Review.
-
The iSEARCH randomised controlled trial protocol: a pragmatic Australian phase III clinical trial of intrapartum sildenafil citrate to improve outcomes potentially related to intrapartum hypoxia.BMJ Open. 2024 Sep 28;14(9):e082943. doi: 10.1136/bmjopen-2023-082943. BMJ Open. 2024. PMID: 39343454 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical